Buchumschlag

Hemodynamic effects of sacubitril/valsartan in patients with reduced left ventricular ejection fraction over 24 months: a retrospective study

The effects of sacubitril/valsartan in patients with chronic heart failure with reduced ejection fraction (HFrEF) were recently reported. However, the hemodynamic impact of this well-established treatment in patients with HFrEF has been poorly systematically researched.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Abumayyaleh, Mohammad S. A. (VerfasserIn) , Demmer, Jonathan (VerfasserIn) , Krack, Carina (VerfasserIn) , Pilsinger, Christina (VerfasserIn) , El-Battrawy, Ibrahim (VerfasserIn) , Behnes, Michael (VerfasserIn) , Aweimer, Assem (VerfasserIn) , Mügge, Andreas (VerfasserIn) , Lang, Siegfried (VerfasserIn) , Akın, Ibrahim (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 30 March 2022
In: American journal of cardiovascular drugs
Year: 2022, Jahrgang: 22, Heft: 5, Pages: 535-544
ISSN:1179-187X
DOI:10.1007/s40256-022-00525-w
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s40256-022-00525-w
Verlag, kostenfrei, Volltext: https://link.springer.com/content/pdf/10.1007/s40256-022-00525-w.pdf?pdf=button
Volltext
Verfasserangaben:Mohammad Abumayyaleh, Jonathan Demmer, Carina Krack, Christina Pilsinger, Ibrahim El-Battrawy, Michael Behnes, Assem Aweimer, Andreas Mügge, Siegfried Lang, Ibrahim Akin
Beschreibung
Zusammenfassung:The effects of sacubitril/valsartan in patients with chronic heart failure with reduced ejection fraction (HFrEF) were recently reported. However, the hemodynamic impact of this well-established treatment in patients with HFrEF has been poorly systematically researched.
Beschreibung:Gesehen am 18.09.2023
Beschreibung:Online Resource
ISSN:1179-187X
DOI:10.1007/s40256-022-00525-w

Ähnliche Einträge